nanotech-investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech-investing Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
nanotech-investing Universal Ibogaine advises further on application for Management Cease Trade Order
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
